trending Market Intelligence /marketintelligence/en/news-insights/trending/4ya7ciak1jcdbfj-htiqyw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Retrophin CEO plans to retire

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Retrophin CEO plans to retire

Retrophin Inc. said Stephen Aselage plans to retire as CEO.

Aselage, who has been CEO since November 2014, will step down after the company identifies his successor.

Retrophin's board has initiated a global search for his successor that will include both internal and external candidates.

San Diego, Calif.-based Retrophin develops treatments for serious or rare diseases. Martin Shkreli, who was convicted of securities fraud in March, is the company's co-founder and former CEO.